S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
OTCMKTS:EKTAY

Elekta AB (publ) - EKTAY Stock Forecast, Price & News

$5.78
+0.12 (+2.12%)
(As of 11/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$5.74
$5.80
50-Day Range
$4.77
$5.87
52-Week Range
$4.68
$12.96
Volume
20,182 shs
Average Volume
29,635 shs
Market Capitalization
$2.22 billion
P/E Ratio
17.51
Dividend Yield
2.70%
Price Target
$69.00

Elekta AB (publ) MarketRank™ Forecast

Analyst Rating
Reduce
1.25 Rating Score
Upside/​Downside
1,094.3% Upside
$69.00 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.55mentions of Elekta AB (publ) in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
28.57%
From $0.28 to $0.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.99 out of 5 stars

EKTAY stock logo

About Elekta AB (publ) (OTCMKTS:EKTAY) Stock

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

EKTAY Stock News Headlines

Elekta AB (publ) (EKTAY)
Elekta AB (publ) (EKTA-B.ST)
ELEKTA B SHS ADR (OTC: EKTAY)
Elekta AB (publ)
Elekta (EKTAY) Presents at ESTRO 2022
Elekta: Interim report, May-January 2021/22
New finance chief at Elekta
EKTAY
Elekta's new sustainability-linked bond oversubscribed
Elekta AB (publ) reports FQ1 results
Report from the Annual General Meeting 2021 in Elekta
Notice to the Annual General Meeting of Elekta AB (publ)
See More Headlines
Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

EKTAY Company Calendar

Ex-Dividend for 9/16 Dividend
8/26/2022
Dividend Payable
9/16/2022
Today
11/30/2022
Fiscal Year End
4/30/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:EKTAY
Employees
4,826
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$69.00
High Stock Price Forecast
$69.00
Low Stock Price Forecast
$69.00
Forecasted Upside/Downside
+1,094.3%
Consensus Rating
Reduce
Rating Score (0-4)
1.25
Research Coverage
4 Analysts

Profitability

Net Income
$129.94 million
Pretax Margin
9.81%

Debt

Sales & Book Value

Annual Sales
$1.64 billion
Cash Flow
$0.68 per share
Book Value
$2.72 per share

Miscellaneous

Free Float
225,231,000
Market Cap
$2.22 billion
Optionable
Not Optionable
Beta
1.03

Key Executives

  • Dr. Laurent Leksell (Age 70)
    Founder & Chairman
  • Mr. Gustaf Salford (Age 45)
    Pres & CEO
  • Mr. Tobias Hagglov (Age 44)
    Chief Financial Officer
  • Cecilia Ketels
    Head of Investor Relations
  • Mr. Jonas Bolander (Age 56)
    Exec. VP of Group Functions, Sec. & Gen. Counsel
  • Mr. Mattias Thorsson
    VP and Head of Corp. Communications & Public Affairs
  • Mr. James P. Hoey (Age 64)
    Head of External Relations
  • Mr. John Lapré (Age 58)
    Pres of Brachy & Neuro Solutions
  • Mr. Maurits Wolleswinkel (Age 51)
    Chief Product Officer
  • Mr. Anming Gong (Age 58)
    Exec. VP of Region China













EKTAY Stock - Frequently Asked Questions

Should I buy or sell Elekta AB (publ) stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last twelve months. There are currently 3 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" EKTAY shares.
View EKTAY analyst ratings
or view top-rated stocks.

What is Elekta AB (publ)'s stock price forecast for 2023?

4 equities research analysts have issued 12 month price targets for Elekta AB (publ)'s stock. Their EKTAY share price forecasts range from $69.00 to $69.00. On average, they anticipate the company's share price to reach $69.00 in the next twelve months. This suggests a possible upside of 1,094.3% from the stock's current price.
View analysts price targets for EKTAY
or view top-rated stocks among Wall Street analysts.

How have EKTAY shares performed in 2022?

Elekta AB (publ)'s stock was trading at $12.80 on January 1st, 2022. Since then, EKTAY stock has decreased by 54.9% and is now trading at $5.7775.
View the best growth stocks for 2022 here
.

Are investors shorting Elekta AB (publ)?

Elekta AB (publ) saw a decrease in short interest in November. As of November 15th, there was short interest totaling 3,900 shares, a decrease of 84.5% from the October 31st total of 25,100 shares. Based on an average daily trading volume, of 69,800 shares, the short-interest ratio is presently 0.1 days.
View Elekta AB (publ)'s Short Interest
.

How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)?

Elekta AB (publ) declared a dividend on Tuesday, August 23rd. Investors of record on Monday, August 29th will be paid a dividend of $0.0809 per share on Friday, September 16th. This represents a yield of 2.43%. The ex-dividend date of this dividend is Friday, August 26th. This is a positive change from the stock's previous dividend of $0.08.
Read our dividend analysis for EKTAY
.

Is Elekta AB (publ) a good dividend stock?

Elekta AB (publ) (OTCMKTS:EKTAY) pays an annual dividend of $0.15 per share and currently has a dividend yield of 2.70%. The dividend payout ratio is 45.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EKTAY will have a dividend payout ratio of 41.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EKTAY.

What is Elekta AB (publ)'s stock symbol?

Elekta AB (publ) trades on the OTCMKTS under the ticker symbol "EKTAY."

How do I buy shares of Elekta AB (publ)?

Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Elekta AB (publ)'s stock price today?

One share of EKTAY stock can currently be purchased for approximately $5.78.

How much money does Elekta AB (publ) make?

Elekta AB (publ) (OTCMKTS:EKTAY) has a market capitalization of $2.22 billion and generates $1.64 billion in revenue each year. The company earns $129.94 million in net income (profit) each year or $0.33 on an earnings per share basis.

How many employees does Elekta AB (publ) have?

The company employs 4,826 workers across the globe.

How can I contact Elekta AB (publ)?

Elekta AB (publ)'s mailing address is P.O. Box 7593, Stockholm V7, SE-103 93. The official website for the company is www.elekta.com. The company can be reached via phone at (685) 872-5400, via email at cecilia.ketels@elekta.com, or via fax at 46-8-587-255-00.

This page (OTCMKTS:EKTAY) was last updated on 11/30/2022 by MarketBeat.com Staff